Angiotensin-converting Enzyme Inhibitors, Inhibition of Brain and Peripheral Angiotensin-converting Enzymes, and Left Ventricular Dysfunction in Rats After Myocardial Infarction
Authors:
- Roselyn WhiteRWRoselyn White
- Junhui TanJTJunhui Tan
- Bing S HuangBHBing S Huang
- Frans Hh LeenenFLFrans Hh Leenen
- 1 June 2008
- journal article
- Published by Wolters Kluwer Health in Journal of Cardiovascular Pharmacology
- Vol. 51 (6) , 565-572
Abstract
The brain renin-angiotensin system contributes significantly to progressive left ventricular (LV) dysfunction in rats after myocardial infarction (MI). The present study evaluated the effects of central versus peripheral plus central angiotensin-converting enzyme (ACE) blockade on sympathetic activity, and LV anatomy and function after MI. Methods: Wistar rats were treated for 4 weeks after MI with the lipophilic ACE inhibitor trandolapril at 5 mg/kg/day or the hydrophilic blocker lisinopril at 50 mg/kg/day by once daily subcutaneous injection, or with a central infusion of lisinopril at 0.1 mg/kg/day. Results: At 24 hours after the last dose, subcutaneous trandolapril caused 70% to 80% ACE inhibition in both brain and kidneys; lisinopril caused 10% to 20% less. Central infusion of lisinopril caused 70% inhibition of brain ACE and minimal (6%) inhibition in the kidneys. All three treatments similarly improved sympathetic reactivity and arterial baroreflex function. All three treatments lowered cardiac Ang I and II, and similarly attenuated the increases in LV end diastolic pressure, circumference, and fibrosis. Both subcutaneous treatments further decreased LV peak systolic pressure and dP/dtmax, whereas icv lisinopril caused no change. Conclusion: Despite marked differences in the extent of peripheral blockade, all three treatments similarly affected sympathetic activity and decreased cardiac Ang II, preload and remodeling after MI. One may speculate that central and peripheral ACE-mediated mechanisms are sequential and therefore only minor additional effects of peripheral ACE blockade are noted.Keywords
This publication has 28 references indexed in Scilit:
- Sympathetic hyperactivity and cardiac dysfunction post-MI: Different impact of specific CNS versus general AT1 receptor blockadeJournal of Molecular and Cellular Cardiology, 2007
- Activation of brain renin-angiotensin-aldosterone system by central sodium in Wistar ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2006
- Multiple signaling pathways are involved in endothelin-1-induced brain endothelial cell migrationAmerican Journal of Physiology-Cell Physiology, 2006
- Prevention of cardiac remodeling after myocardial infarction in transgenic rats deficient in brain angiotensinogenJournal of Molecular and Cellular Cardiology, 2005
- Simvastatin Therapy Normalizes Sympathetic Neural Control in Experimental Heart FailureCirculation, 2005
- Blockade of brain mineralocorticoid receptors or Na+ channels prevents sympathetic hyperactivity and improves cardiac function in rats post-MIAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Brain angiotensin-converting enzyme activity and autonomic regulation in heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Increases in brain and cardiac AT1 receptor and ACE densities after myocardial infarct in ratsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2004
- Prevention of Sympathetic and Cardiac Dysfunction After Myocardial Infarction in Transgenic Rats Deficient in Brain AngiotensinogenCirculation Research, 2004
- Angiotensin and bradykinin peptides in rats with myocardial infarctionJournal of Cardiac Failure, 1997